Cordis Corp.

Company to ask judge to overturn Cypher patent verdict

Published in Physician Law Weekly, August 3rd, 2005

Cordis Corp., a Johnson & Johnson company, will ask U.S. District Court Judge Sue Robinson to overturn a jury finding that found Boston Scientific's Ding and Jang patents to be valid and infringed by Cordis' CYPHER Sirolimus-eluting Stent and Bx Velocity family of stent products.

Cordis believes the verdict was not supported by the evidence and will ask the judge to reverse it. If the verdict is not overturned, Cordis will appeal to the Court of Appeals for the Federal Circuit in Washington, DC.

The Ding patent, which Boston Scientific asserted against CYPHER, claims a 2-layer drug coating on a drug-eluting stent. The Jang patent, which was asserted...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2005-08-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry